MEDCHEM NEWS
Online ISSN : 2432-8626
Print ISSN : 2432-8618
ISSN-L : 2432-8618
Axcelead: Your best partner for innovation in a new trend of drug discovery
Yoshinori IkeuraTakahiro Tanaka
Author information
JOURNAL FREE ACCESS

2022 Volume 32 Issue 4 Pages 178-183

Details
Abstract
Axcelead Drug Discovery Partners (Axcelead DDP) Inc. is the first solution provider of integrated drug discovery in Japanese pharmaceutical industry. Experienced drug discovery researchers will promote drug discovery research together with customers and contribute to creation of innovative drugs by making full use of the drug discovery platform and knowledge inherited from Takeda Pharmaceutical Company, Ltd., and incorporating the brand-new science and technology. In this column we overview changes in the environment surrounding pharmaceutical industry and new trends in drug discovery research, and introduce Axcelead DDP’s research organizational structure, its unique strengths, and the value (solutions) delivered to customers. In addition, we touch on current situation of the Japanese bio-community and describe the roles and challenges of Axcelead DDP for the establishment / development of a drug discovery ecosystem in Japan.
Content from these authors
Previous article Next article
feedback
Top